The Endothelial Cell Dysfunction and Outcome Project for Hematological Neoplasms

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

June 7, 2027

Study Completion Date

June 7, 2032

Conditions
Hematological NeoplasmEndothelial Dysfunction
Interventions
DIAGNOSTIC_TEST

Sublingual in vivo microscopy with the Glycocheck microscope

For the collection of longitudinal microscopy data, sublingual in vivo microscopy with the Glycocheck microscope will be performed at the following timepoints: 2-3 x between day (D) -28 of allogeneic HSCT or CAR T cell therapy and before start of the conditioning regimen, once between D2-D14, once between D15-28, once between D30- D100 and at the onset of endothelial complications such as acute GvHD, TMA, sepsis, VOD and IPS following allogeneic HSCT or CAR T cell therapy. Sublingual microscopy requires 15-30 minutes and is similar to sublingual temperature measurement. To this extent, a tube with a diameter of approximately 1cm carrying a microscope at the tip is inserted into the mouth and under the tongue to measure endothelial structures (blood flow through small capillaries). Biological samples are collected and processed within the established Biobank of the Internal Medicine V of the Heidelberg University Hospital.

Trial Locations (1)

69120

RECRUITING

Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg

All Listed Sponsors
lead

Prof. Dr. Thomas Luft

OTHER